IntelliPharmaCeutics International (IPCI)

Add to Watchlists Create an Alert
1.84 +0.01  +0.55%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

IntelliPharmaCeutics International Revenue Quarterly YoY Growth:

-100.0% for Feb. 28, 2013
View Full Chart

IntelliPharmaCeutics International Revenue Quarterly YoY Growth Chart

    IntelliPharmaCeutics International Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Feb. 28, 2013 -100.0%
    Nov. 30, 2012
    Aug. 31, 2012 -100.0%
    May 31, 2012
    Feb. 29, 2012
    Nov. 30, 2011 -100.0%
    Aug. 31, 2011
    May 31, 2011 -100.0%
    Feb. 28, 2011 -100.0%
    Nov. 30, 2010
    Aug. 31, 2010
    May 31, 2010
    Feb. 28, 2010
    Aug. 31, 2009
    May 31, 2009
    Feb. 28, 2009
    Nov. 30, 2008
    Aug. 31, 2008
    May 31, 2008
    Feb. 29, 2008 Go Pro
    Nov. 30, 2007 Go Pro
    Aug. 31, 2007 Go Pro
    May 31, 2007 Go Pro
    Feb. 28, 2007 Go Pro
    Nov. 30, 2006 Go Pro
       
    Aug. 31, 2006 Go Pro
    May 31, 2006 Go Pro
    Feb. 28, 2006 Go Pro
    Nov. 30, 2005 Go Pro
    Aug. 31, 2005 Go Pro
    May 31, 2005 Go Pro
    Feb. 28, 2005 Go Pro
    Nov. 30, 2004 Go Pro
    Aug. 31, 2004 Go Pro
    May 31, 2004 Go Pro
    Feb. 29, 2004 Go Pro
    Nov. 30, 2003 Go Pro
    Aug. 31, 2003 Go Pro
    May 31, 2003 Go Pro
    Feb. 28, 2003 Go Pro
    Nov. 30, 2002 Go Pro
    Aug. 31, 2002 Go Pro
    May 31, 2002 Go Pro
    Feb. 28, 2002 Go Pro
    Nov. 30, 2001 Go Pro
    Aug. 31, 2001 Go Pro
    May 31, 2001 Go Pro
    Feb. 28, 2001 Go Pro
    Nov. 30, 2000 Go Pro
    Aug. 31, 2000 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    IPCI Revenue Quarterly YoY Growth Benchmarks

    Companies
    Celgene Corporation 15.02%
    Elan 0.00%
    ARCA biopharma

    IPCI Revenue Quarterly YoY Growth Rankings

    Overall 38th percentile
    4899 of 8006
    Sector 24th percentile
    515 of 686 in Healthcare
    Industry 40th percentile
    148 of 248 in Biotechnology

    IPCI Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -100.0% Feb 2011
    Maximum -100.0% Feb 2011
    Average -100.0%